Defining a start-up plan based on key study objectives
Using a data driven approach for effective start-up planning, including data from regulatory intelligence, site intelligence, and KPIs to support start-up planning
How effective start-up execution drives a successful trial
Exposing the inefficiencies of current vendor qualification practices and challenging the industry to adopt a proven process innovation that will help sponsors onboard vendors more quickly leading to a real reduction in clinical trial start-up times
Learn how embracing innovation, and adopting a risk-based data-driven approach to vendor management can help organizations strength their compliance practices in a heavily regulated industry
Uncover the advantages of a centralized approach to vendor qualification that provides unique benefits to both sponsors and vendors across the globe
Navigating global data restrictions: Lowering concerns and finding solutions regarding the limitations on research imposed by GDPR in the EU
Sharing best practice for scaling studies across multiple states and countries despite a lack of consistency with regulations
Looking at the intersection of data privacy and sample ownership regulations with the business imperative to address new questions that may arise during study analysis
Addressing concerns at the protocol and ICF development phase
